Evidence map›Paper›PMID 27462430›Full record

ArticleCell discovery2015

Increased dysbindin-1B isoform expression in schizophrenia and its propensity in aggresome formation.

Yiliang Xu, Yuhui Sun, Haihong Ye, Li Zhu, Jianghong Liu, Xiaofeng Wu, Le Wang, Tingting He, Yan Shen, Jane Y Wu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell discovery, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.International journal of molecular sciences · 2018
    Review
  11. Article
  12. Dysbindin-1 Involvement in the Etiology of Schizophrenia.International journal of molecular sciences · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Yiliang XuNational Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Tsinghua University, Beijing, China; Department of Medical Genetics, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Yuhui SunNational Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Tsinghua University , Beijing, China.
Haihong YeDepartment of Medical Genetics, School of Basic Medical Sciences, Capital Medical University, Beijing, China; The State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Li ZhuThe State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences , Beijing, China.
Jianghong LiuThe State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences , Beijing, China.
Xiaofeng WuNational Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Tsinghua University , Beijing, China.
Le WangNational Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Tsinghua University , Beijing, China.
Tingting HeNational Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Tsinghua University , Beijing, China.
Yan ShenNational Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Tsinghua University , Beijing, China.
Jane Y WuThe State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China; Department of Neurology, Center of Genetic Medicine, Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Qi XuNational Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Tsinghua University , Beijing, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNTsinghua University · CNChinese Academy of Sciences · CNCapital Medical University · CNInstitute of Biophysics · CN

Funding

Mechanisms regulating tau alternative pre-mRNA splicingR01AG033004 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WU, JANE Y · 2011 to 2015
$1.5M
Searching for Genetic Modifiers of TDP-43 Proteinopathy Using an Animal ModelR56NS074763 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WU, JANE Y · 2011 to 2011
$375k
NIA NIH HHS R01 AG033004NINDS NIH HHS R56 NS074763
6 · The paper itself

Abstract

Genetic variations in the human dysbindin-1 gene (DTNBP1) have been associated with schizophrenia. As a result of alternative splicing, the human DTNBP1 gene generates at least three distinct protein isoforms, dysbindin-1A, -1B and -1C. Significant effort has focused on dysbindin-1A, an important player in multiple steps of neurodevelopment. However, the other isoforms, dysbindin-1B and dysbindin-1C have not been well characterized. Nor have been associated with human diseases. Here we report an increase in expression of DTNBP1b mRNA in patients with paranoid schizophrenia as compared with healthy controls. A single-nucleotide polymorphism located in intron 9, rs117610176, has been identified and associated with paranoid schizophrenia, and its C allele leads to an increase of DTNBP1b mRNA splicing. Our data show that different dysbindin splicing isoforms exhibit distinct subcellular distribution, suggesting their distinct functional activities. Dysbindin-1B forms aggresomes at the perinuclear region, whereas dysbindin-1A and -1C proteins exhibit diffused patterns in the cytoplasm. Dysbindin-1A interacts with dysbindin-1B, getting recruited to the aggresome structure when co-expressed with dysbindin-1B. Moreover, cortical neurons over-expressing dysbindin-1B show reduction in neurite outgrowth, suggesting that dysbindin-1B may interfere with dysbindin-1A function in a dominant-negative manner. Taken together, our study uncovers a previously unknown association of DTNBP1b expression with schizophrenia in addition to its distinct biochemical and functional properties.

Indexed as

dysbindin-1neurite outgrowthprotein aggregationschizophrenia

Identifiers

PMID27462430
PMCPMC4860834
OpenAlexW2520280275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.